Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2019

01-01-2019 | Correction

Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer

Authors: K. A. Nyrop, A. M. Deal, S. K. Choi, C. W. Wagoner, J. T. Lee, W. A. Wood, C. Anders, L. A. Carey, E. C. Dees, T. A. Jolly, K. E. Reeder-Hayes, H. B. Muss

Published in: Breast Cancer Research and Treatment | Issue 1/2019

Login to get access

Excerpt

In the original publication, the sixth author name was published incorrectly as A. Wood. The correct author name should read as W. A. Wood. …
Metadata
Title
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer
Authors
K. A. Nyrop
A. M. Deal
S. K. Choi
C. W. Wagoner
J. T. Lee
W. A. Wood
C. Anders
L. A. Carey
E. C. Dees
T. A. Jolly
K. E. Reeder-Hayes
H. B. Muss
Publication date
01-01-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4975-8

Other articles of this Issue 1/2019

Breast Cancer Research and Treatment 1/2019 Go to the issue

Review

T-Type voltage gated calcium channels: a target in breast cancer?

Review

Male breast cancer: a disease distinct from female breast cancer

Clinical trial

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

Preclinical study

Alternative splicing is an important mechanism behind KAI1 loss of function in breast cancer patients from Saudi Arabia

Epidemiology

Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates

Clinical trial

Dietary intervention among breast cancer survivors increased adherence to a Mediterranean-style, anti-inflammatory dietary pattern: the Rx for Better Breast Health Randomized Controlled Trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits